Kursinformationen zu State Street® SPDR® S&P® Pharmaceuticals ETF

State Street® SPDR® S&P® Pharmaceuticals ETF
Valor -
66.81USD0.64USD+0.96%
28.09.2026
Kursdaten28.09.2026
NAV in CHF
66.81
Tagesveränderung relativ
+0.96%
Tagesveränderung absolut
0.64
NAV Vortag
66.17
Letzter Handel
28.09.2026
Konditionen
Ausgabekommissionen
+0.00%
Verwaltungsgebühr
+0.35%
OGC
0.00 %
Dokumente
Monatsbericht
-
Halbjahresbericht
-
Jahresbericht
-
Vollständiger Prospekt
-
Gesetzl. Publikationen
-
Strategie

The State Street SPDR S&P Pharmaceuticals ETF (the "Fund") seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the pharmaceuticals segment of a U.S. total market composite index. In seeking to track the performance of the S&P Pharmaceuticals Select Industry Index (the "Index"), the Fund employs a sampling strategy, which means that the Fund is not required to purchase all of the securities represented in the Index. Instead, the Fund may purchase a subset of the securities in the Index in an effort to hold a portfolio of securities with generally the same risk and return characteristics of the Index. The quantity of holdings in the Fund will be based on a number of factors, including asset size of the Fund. Based on its analysis of these factors, SSGA Funds Management, Inc. ("SSGA FM" or the "Adviser"), the investment adviser to the Fund, either may invest the Fund's assets in a subset of securities in the Index or may invest the Fund's assets in substantially all of the securities represented in the Index in approximately the same proportions as the Index, as determined by the Adviser to be in the best interest of the Fund in pursuing its objective.

Kursentwicklung / Kennzahlen
ZeitraumPerformanceVolatilitätSharpe RatioBester MonatSchlecht. MonatMax Verlust
YTD+19.44%+23.01%+1.06%+13.99%-5.85%-11.78%
6 Monate+30.17%+23.36%+2.87%+13.99%-5.85%-10.64%
1 Jahr+41.30%+22.31%+1.74%+13.99%-5.85%-11.78%
3 Jahre+72.03%+20.29%+0.85%+14.97%-9.85%-23.45%
5 Jahre---+14.97%-9.85%-
Stammdaten
ISIN
US78464A7220
Valor
-
Währung
USD
Anlageklasse
Alternative Investm.
UCITS
nein
Branche
ETF Aktien
Anlageregion
-
Domizil
USA
Vertriebszulassung
USA
Auflagedatum
19.06.2006
Volumen
544'496'695.52
Geschäftsjahresbeginn
01.07.2026
Depotbank
State Street Global Advisors
Emittent
SSGA FM
Grösste Positionen
Amylyx Pharmaceuticals Inc.
3.65 %
Crinetics Pharmaceuticals Inc.
3.60 %
Omeros Corp.
2.68 %
Enliven Therapeutics Inc.
2.28 %
Nuvation Bio Inc.
2.12 %
Corcept Therapeutics Inc.
2.11 %
Eton Pharmaceuticals Inc.
2.08 %
Perrigo Co. PLC
1.91 %
Edgewise Therapeutics Inc.
1.85 %
Merck & Co. Inc.
1.81 %
Zusammensetzung nach Branchen
Gesundheitswesen
78.17 %